Drug sensitivity of Leishmania species: some unresolved problems (Q34677098)

3 August 2017

1 reference

title

Drug sensitivity of Leishmania species: some unresolved problems (English)

1 reference

3 August 2017

Simon L Croft

1

1 reference

PubMed ID

12055825

3 August 2017

Vanessa Yardley

series ordinal

2

1 reference

PubMed ID

12055825

3 August 2017

Howard Kendrick

series ordinal

3

1 reference

3 August 2017

1 April 2002

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

3 August 2017

1 reference

3 August 2017

96 Suppl 1

1 reference

3 August 2017

S127-9

1 reference

Comparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

In Vitro Susceptibility of Antimony-Resistant Leishmania to Alternative Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Dissecting the biology of a pathogen during infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

A simple method for quantifying Leishmania in tissues of infected animals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

The sensitivity of Leishmania species to aminosidine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

A new standard for the assessment of disease progression in murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990063-5

7 January 2021

10.1016/S0035-9203(02)90063-5

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12055825